Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy

Journal of the American Society of Nephrology

Volumn 22, Issue 8, 2011, Pages 1543-1550

  Beck, Laurence H ^a   Fervenza, Fernando C ^b   Beck, David M ^a   Bonegio, Ramon G B ^a   Malik, Fahim A ^a   Erickson, Stephen B ^b   Cosio, Fernando G ^b   Cattran, Daniel C ^c   Salant, David J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2 RECEPTOR; RITUXIMAB;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 79960948754     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010111125     Document Type: Article

References (16)

1. Cattran D: Management of membranous nephropathy: When and what for treatment. J Am Soc Nephrol 16: 1188-1194, 2005
2. Bomback AS, Derebail VK, McGregor JG, Kshirsagar AV, Falk RJ, Nachman PH: Rituximab therapy for membranous nephropathy: A systematic review. Clin J Am Soc Nephrol 4: 734-744, 2009
3. El-Zoghby ZM, Grande JP, Fraile MG, Norby SM, Fervenza FC, Cosio, FG: Recurrent idiopathic membranous nephropathy: Early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant 9: 2800-2807, 2009
4. Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC: Rituximab therapy in idiopathic membranous nephropathy: A 2-year study. Clin J Am Soc Nephrol 5: 2188-2198, 2010
5. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC: Rituximab treatment of idiopathic membranous nephropathy. Kidney Int 73: 117-125, 2008 (Pubitemid 350273646)
6. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P: Rituximab for idiopathic membranous nephropathy. Lancet 360: 923-924, 2002 (Pubitemid 35283838)
7. Sprangers B, Lefkowitz GI, Cohen SD, Stokes MB, Valeri A, Appel GB, Kunis CL: Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation. Clin J Am Soc Nephrol 5: 790-797, 2010
8. 2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
9. 2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22: 1137-1143, 2011
10. 2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 1286-1291, 2011
11. Beck LH Jr, Salant DJ: Membranous nephropathy: Recent travels and new roads ahead. Kidney Int 77: 765-770, 2010
12. Ruggenenti P, Cravedi P, Sghirlanzoni MC, Gagliardini E, Conti S, Gaspari F, Marchetti G, Abbate M, Remuzzi G: Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy. Clin J Am Soc Nephrol 3: 1652-1659, 2008
13. Makker SP, Kanalas JJ: Course of transplanted Heymann nephritis kidney in normal host. Implications for mechanism of proteinuria in membranous glomerulonephropathy. J Immunol 142: 3406-3410, 1989 (Pubitemid 19137466)
14. Polanco N, Gutierrez E, Covarsi A, Ariza F, Carreno A, Vigil A, Baltar J, Fernandez-Fresnedo G, Martin C, Pons S, Lorenzo D, Bernis C, Arrizabalaga P, Fernandez-Juarez G, Barrio V, Sierra M, Castellanos I, Espinosa M, Rivera F, Oliet A, Fernandez-Vega F, Praga M: Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21: 697-704, 2010
15. Prunotto M, Carnevali ML, Candiano G, Murtas C, Bruschi M, Corradini E, Trivelli A, Magnasco A, Petretto A, Santucci L, Mattei S, Gatti R, Scolari F, Kador P, Allegri L, Ghiggeri GM: Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 21: 507-519, 2010
16. Ronco P, Debiec H: First identification of an antigen in autoimmune idiopathic membranous nephropathy: Toward targeted therapy? Am J Kidney Dis 55: 820-823, 2010